Neuroprotective effects of infliximab in experimental spinal cord injury

Surgical Neurology

Volumn 71, Issue 3, 2009, Pages 332-336

  Kurt, Gökhan ^a   Ergün, Ertan ^a   Cemil, Berker ^a   Börcek, Alp Özgün ^a   Börcek, Pelin ^a   Gülbahar, Özlem ^a   Çeviker, Necdet ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Infliximab; Neuroprotective agents; Spinal cord injury; TNF

Indexed keywords

INFLIXIMAB; LIPID PEROXIDE; MALONALDEHYDE; METHYLPREDNISOLONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; LAMINECTOMY; MALE; NEUROPROTECTION; NONHUMAN; RAT; SPINAL CORD COMPRESSION; SPINAL CORD INJURY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; INJECTIONS, INTRAPERITONEAL; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; METHYLPREDNISOLONE; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; RECOVERY OF FUNCTION; SPINAL CORD COMPRESSION; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 60649089249     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surneu.2008.01.038     Document Type: Article

References (51)

1. Balentine J.D. Pathology of experimental spinal cord trauma. II. Ultrastructure of axons and myelin. Lab Invest 39 3 (1978) 254-266
2. Bao F., Chen Y., Dekaban G.A., and Weaver L.C. An anti-CD11d integrin antibody reduces cyclooxygenase-2 expression and protein and DNA oxidation after spinal cord injury in rats. J Neurochem 90 5 (2004) 1194-1204
3. Beta-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 247 12 (1982) 1707-1714
4. Bracken M.B. Steroids for acute spinal cord injury. Cochrane Database Syst Rev 3 (2002) CD001046
5. Carlson S.L., Parrish M.E., Springer J.E., Doty K., and Dossett L. Acute inflammatory response in spinal cord following impact injury. Exp Neurol 151 1 (1998) 77-88
6. Choy E.H., and Panayi G.S. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344 12 (2001) 907-916
7. Crowe M.J., Bresnahan J.C., Shuman S.L., Masters J.N., and Beattie M.S. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med 3 1 (1997) 73-76
8. Demediuk P., Saunders R.D., Clendenon N.R., Means E.D., Anderson D.K., and Horrocks L.A. Changes in lipid metabolism in traumatized spinal cord. Prog Brain Res 63 (1985) 211-226
9. Demir T., Godekmerdan A., Balbaba M., Turkcuoglu P., Ilhan F., and Demir N. The effect of infliximab, cyclosporine A and recombinant IL-10 on vitreous cytokine levels in experimental autoimmune uveitis. Indian J Ophthalmol 54 4 (2006) 241-245
10. Diaz-Ruiz A., Rios C., Duarte I., Correa D., Guizar-Sahagun G., Grijalva I., Madrazo I., and Ibarra A. Lipid peroxidation inhibition in spinal cord injury: cyclosporin-A vs methylprednisolone. Neuroreport 11 8 (2000) 1765-1767
11. Ducker T.B., Kindt G.W., and Kempf L.G. Pathological findings in acute experimental spinal cord trauma. J Neurosurg 35 6 (1971) 700-708
12. Faden A.I., and Simon R.P. A potential role for excitotoxins in the pathophysiology of spinal cord injury. Ann Neurol 23 6 (1988) 623-626
13. Fehlings M.G., Tator C.H., and Linden R.D. The relationships among the severity of spinal cord injury, motor and somatosensory evoked potentials and spinal cord blood flow. Electroencephalogr Clin Neurophysiol 74 4 (1989) 241-259
14. Hall E.D. Inhibition of lipid peroxidation in CNS trauma. J Neurotrauma 8 Suppl 1 (1991) S31-S40 discussion S1
15. Hall E.D. Lipid antioxidants in acute central nervous system injury. Ann Emerg Med 22 6 (1993) 1022-1027
16. Hall E.D. The neuroprotective pharmacology of methylprednisolone. J Neurosurg 76 1 (1992) 13-22
17. Hamada Y., Ikata T., Katoh S., Nakauchi K., Niwa M., Kawai Y., and Fukuzawa K. Involvement of an intercellular adhesion molecule 1-dependent pathway in the pathogenesis of secondary changes after spinal cord injury in rats. J Neurochem 66 4 (1996) 1525-1531
18. Holtz A., Nystrom B., Gerdin B., and Olsson Y. Neuropathological changes and neurological function after spinal cord compression in the rat. J Neurotrauma 7 3 (1990) 155-167
19. Ildan F., Polat S., Oner A., Isbir T., Gocer A.I., Tap O., Kaya M., and Karadayi A. Effects of naloxone on sodium- and potassium-activated and magnesium-dependent adenosine-5¢-triphosphatase activity and lipid peroxidation and early ultrastructural findings after experimental spinal cord injury. Neurosurgery 36 4 (1995) 797-805
20. Kapadia M.K., and Rubin P.A. The emerging use of TNF-alpha inhibitors in orbital inflammatory disease. Int Ophthalmol Clin 46 2 (2006) 165-181
21. Kaptanoglu E., Beskonakli E., Solaroglu I., Kilinc A., and Taskin Y. Magnesium sulfate treatment in experimental spinal cord injury: emphasis on vascular changes and early clinical results. Neurosurg Rev 26 4 (2003) 283-287
22. Kaptanoglu E., Caner H.H., Surucu H.S., and Akbiyik F. Effect of mexiletine on lipid peroxidation and early ultrastructural findings in experimental spinal cord injury. J Neurosurg 91 2 Suppl (1999) 200-204
23. Kaptanoglu E., Solaroglu I., Okutan O., Surucu H.S., Akbiyik F., and Beskonakli E. Erythropoietin exerts neuroprotection after acute spinal cord injury in rats: effect on lipid peroxidation and early ultrastructural findings. Neurosurg Rev 27 2 (2004) 113-120
24. Kaptanoglu E., Tuncel M., Palaoglu S., Konan A., Demirpence E., and Kilinc K. Comparison of the effects of melatonin and methylprednisolone in experimental spinal cord injury. J Neurosurg 93 1 Suppl (2000) 77-84
25. Klebanoff S.J., Vadas M.A., Harlan J.M., Sparks L.H., Gamble J.R., Agosti J.M., and Waltersdorph A.M. Stimulation of neutrophils by tumor necrosis factor. J Immunol 136 11 (1986) 4220-4225
26. Koc R.K., Akdemir H., Karakucuk E.I., Oktem I.S., and Menku A. Effect of methylprednisolone, tirilazad mesylate and vitamin E on lipid peroxidation after experimental spinal cord injury. Spinal Cord 37 1 (1999) 29-32
27. Kuek A., Hazleman B.L., and Ostor A.J. Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution. Postgrad Med J 83 978 (2007) 251-260
28. Kulmatycki K.M., Abouchehade K., Sattari S., and Jamali F. Drug-disease interactions: reduced beta-adrenergic and potassium channel antagonist activities of sotalol in the presence of acute and chronic inflammatory conditions in the rat. Br J Pharmacol 133 2 (2001) 286-294
29. Liu X.Z., Xu X.M., Hu R., Du C., Zhang S.X., McDonald J.W., Dong H.X., Wu Y.J., Fan G.S., Jacquin M.F., Hsu C.Y., and Choi D.W. Neuronal and glial apoptosis after traumatic spinal cord injury. J Neurosci 17 14 (1997) 5395-5406
30. Maini R.N., and Taylor P.C. Anti-cytokine therapy for rheumatoid arthritis. Annu Rev Med 51 (2000) 207-229
31. Markham A., and Lamb H.M. Infliximab: a review of its use in the management of rheumatoid arthritis. Drugs 59 6 (2000) 1341-1359
32. Means E.D., and Anderson D.K. Neuronophagia by leukocytes in experimental spinal cord injury. J Neuropathol Exp Neurol 42 6 (1983) 707-719
33. Mihara M., and Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 86 1 (1978) 271-278
34. Mizuno Y., and Ohta K. Regional distributions of thiobarbituric acid-reactive products, activities of enzymes regulating the metabolism of oxygen free radicals, and some of the related enzymes in adult and aged rat brains. J Neurochem 46 5 (1986) 1344-1352
35. Mulligan M.S., Varani J., Dame M.K., Lane C.L., Smith C.W., Anderson D.C., and Ward P.A. Role of endothelial-leukocyte adhesion molecule 1 (ELAM-1) in neutrophil-mediated lung injury in rats. J Clin Invest 88 4 (1991) 1396-1406
36. Nesic O., Xu G.Y., McAdoo D., High K.W., Hulsebosch C., and Perez-Pol R. IL-1 receptor antagonist prevents apoptosis and caspase-3 activation after spinal cord injury. J Neurotrauma 18 9 (2001) 947-956
37. Olmarker K., and Rydevik B. Selective inhibition of tumor necrosis factor-alpha prevents nucleus pulposus-induced thrombus formation, intraneural edema, and reduction of nerve conduction velocity: possible implications for future pharmacologic treatment strategies of sciatica. Spine 26 8 (2001) 863-869
38. Qian H., and Liu D. The time course of malondialdehyde production following impact injury to rat spinal cord as measured by microdialysis and high pressure liquid chromatography. Neurochem Res 22 10 (1997) 1231-1236
39. Rawe S.E., Lee W.A., and Perot P.L. Spinal cord glucose utilization after experimental spinal cord injury. Neurosurgery 9 1 (1981) 40-47
40. Schmidley J.W. Free radicals in central nervous system ischemia. Stroke 21 7 (1990) 1086-1090
41. Taoka Y., and Okajima K. Spinal cord injury in the rat. Prog Neurobiol 56 3 (1998) 341-358
42. Taoka Y., Okajima K., Uchiba M., Murakami K., Harada N., Johno M., and Naruo M. Activated protein C reduces the severity of compression-induced spinal cord injury in rats by inhibiting activation of leukocytes. J Neurosci 18 4 (1998) 1393-1398
43. Taoka Y., Okajima K., Uchiba M., Murakami K., Kushimoto S., Johno M., Naruo M., Okabe H., and Takatsuki K. Role of neutrophils in spinal cord injury in the rat. Neuroscience 79 4 (1997) 1177-1182
44. Tator C.H. Biology of neurological recovery and functional restoration after spinal cord injury. Neurosurgery 42 4 (1998) 696-707 discussion-8
45. Tator C.H., and Fehlings M.G. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 75 1 (1991) 15-26
46. Usul H., Cakir E., Arslan E., Peksoylu B., Alver A., Sayin O.C., Topbas M., and Baykal S. Effects of clotrimazole on experimental spinal cord injury. Arch Med Res 37 5 (2006) 571-575
47. Wang C.X., Nuttin B., Heremans H., Dom R., and Gybels J. Production of tumor necrosis factor in spinal cord following traumatic injury in rats. J Neuroimmunol 69 1-2 (1996) 151-156
48. Xu J.A., Hsu C.Y., Liu T.H., Hogan E.L., Perot Jr. P.L., and Tai H.H. Leukotriene B4 release and polymorphonuclear cell infiltration in spinal cord injury. J Neurochem 55 3 (1990) 907-912
49. Yakovlev A.G., and Faden A.I. Sequential expression of c-fos protooncogene, TNF-alpha, and dynorphin genes in spinal cord following experimental traumatic injury. Mol Chem Neuropathol 23 2-3 (1994) 179-190
50. Zheng H., Crowley J.J., Chan J.C., Hoffmann H., Hatherill J.R., Ishizaka A., and Raffin T.A. Attenuation of tumor necrosis factor-induced endothelial cell cytotoxicity and neutrophil chemiluminescence. Am Rev Respir Dis 142 5 (1990) 1073-1078
51. Zileli M., and Özer F. Pharmacological treatment in spinal cord injuries. In: Zileli M., and Özer F. (Eds). Spinal cord and spine surgery (1997), Saray, Izmir